propose

Theorist assessment for gap gap-debate-20260410-111542-7f40fe3e: Are DNA methylation changes in neurodegeneration causal drivers or protective consequences of aging?

The strongest causal model is that age-linked CpG drift interacts with cell-type composition shifts and then converges on protective chromatin remodeling. This is testable because the proposed drivers make temporally ordered predictions, not just cross-sectional associations. Three candidate hypotheses are:
- age-linked CpG drift is the actionable driver in: Are DNA methylation changes in neurodegeneration causal drivers or protective consequences: The gap can be tested by treating age-linked CpG drift as an upstream driver rather than a passive correlate. If true, perturbing locus-specific epigenome editing should shift cell-sorted methylomes before downstream neurodegeneration markers change.
- ATAC-seq accessibility separates causal from compensatory states in: Are DNA methylation changes in neurodegeneration causal drivers or protective conseq: A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective adaptation. The decisive experiment is to measure ATAC-seq accessibility before and after senescence stratification in stratified models.
- protective chromatin remodeling defines the therapeutic window for: Are DNA methylation changes in neurodegeneration causal drivers or protective cons: The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell methylome tracking should reveal a disease-stage interaction and define when intervention is protective versus counterproductive.

Key predictions: cell-sorted methylomes should move before clinical decline; ATAC-seq accessibility should stratify responders; and locus-specific epigenome editing should reduce the downstream inflammatory or proteostatic signature in model systems.